MABVAX THERAPEUTICS HLDGS IN

CUSIP: 55414P702 Class: COM PAR

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q2 2018
Shares 11,889 Value ($000) $10 Avg Close — Range —
Q1 2018
Shares 1,652 Value ($000) $2 Avg Close — Range —